Single-Use Technology for Biologics Manufacturing in St. Louis, Missouri

Learn about Thermo Fisher Scientific’s expansion of its biologics site in St. Louis, Missouri. The facility will be the single largest single-use technology CDMO in the United States.

関連する施設紹介

関連する各種資料

Manufacturing Process Scale-up for Phase III: Clear Sailing or Storms Ahead?

Manufacturing Innovation: The Case for Continuous Manufacturing

Navigating Decision Points to Fast-Track Commercialisation

Steriles Drug Development & Manufacturing: Flexibility and Optimization

Growing Your Biopharma: Ten Questions You're Likely to Face From Investors—And How to Respond to Them

A Tale of Two CDMOs: Which Choice Will Your Biopharma Make?

Navigating the Adoption of Continuous Manufacturing Amid Unprecedented Global Challenges

Impact of a Pandemic Outbreak on Vaccine Development Approach

Analytical Considerations For Biopharmaceuticals During Commercialization

Benefits of 5KL Bioreactor When Outsourcing Late-phase Biologics Drug Substance Manufacturing

Practical Implementation of Innovative and Scalable Technologies to Accelerate Biologics Development and Commercialization: A CDMO Perspective

Leveraging Infrastructure Investments and Innovation to Accelerate Biologics Development

Accelerating Cell Culture Development through Practical Application of Innovation Technologies

Leveraging Innovative Technologies, Best Practices and Strategies to Accelerate Biologics Development and Commercialization

Continuous Manufacturing: The Alternative to Batch Manufacturing

What You Need to Know About Process Characterization and Validation For Biologic Processes

Telltale Signs You're with the Wrong CDMO

Choosing the Right CDMO for Late Phase Clinical Trials

Biopharma Capabilities Overview

Pharma Services Overview Brochure

Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas

Biologics Overview: Flexible Biomanufacturing Solutions

Technology Transfers: Reaping Rewards, Reducing Risks

Top Five Risks Facing Your Small Biopharma Clients Today

Multiplexing: Managing Risk with Proven, Single-Use Solutions